Photo by nci from unsplash
Coronavirus disease 2019 (COVID‐19) is associated with hypercoagulability and increased thrombotic risk. The impact of prehospital antiplatelet therapy on in‐hospital mortality is uncertain. Click to show full abstract
Coronavirus disease 2019 (COVID‐19) is associated with hypercoagulability and increased thrombotic risk. The impact of prehospital antiplatelet therapy on in‐hospital mortality is uncertain.
Keywords:
prehospital antiplatelet;
antiplatelet therapy;
therapy survival;
association prehospital
Journal Title: Journal of Thrombosis and Haemostasis
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Thrombosis and Haemostasis
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!